Index/Organizations/Bristol-Myers Squibb

Bristol-Myers Squibb

American pharmaceutical company

Fact-Checks

8 results
Jan 3, 2026
Most Viewed

Which major corporations and pharmaceutical companies provide funding to the American Heart Association?

The American Heart Association (AHA) regularly discloses a multi-year roster of corporate donors that includes numerous pharmaceutical, biotech and medical-device firms; its published “pharma funding”...

Dec 22, 2025
Most Viewed

Which 15 cancer indications are specifically listed in the MHRA approval for injectable nivolumab?

The MHRA’s April 30, 2025 announcement authorised a subcutaneous (under‑the‑skin) formulation of nivolumab for use across a broad range of solid‑tumour indications and stated the approval covers 15 ca...

Jan 3, 2026

Which pharmaceutical companies have been largest donors to the American Heart Association in the last decade?

The American Heart Association (AHA) publishes year-by-year disclosures listing pharmaceutical, biotech and device-company support, and those disclosures show a recurring set of large donors across th...

Dec 30, 2025

Which specific drugs and manufacturers agreed to TrumpRx pricing and what are the exact price changes?

Nine major drugmakers — Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech (Roche’s U.S. unit), Gilead Sciences, GSK (including ViiV), Merck, Novartis and Sanofi — agreed to sell selected me...

Dec 21, 2025

Is there a new NHS injection for cancer patients that helps with 15 cancer types?

The NHS has begun rolling out an under‑the‑skin injectable form of the immunotherapy drug nivolumab (Opdivo) that regulators have approved as an alternative to the intravenous infusion, and NHS Englan...

Dec 20, 2025

did drug companies agree to lower prices

Yes — nine major pharmaceutical companies publicly agreed to lower the price of some of their medicines in deals announced by the Trump administration on Dec. 19, 2025, committing to “most-favored-nat...

Dec 20, 2025

What large ongoing randomized trials are testing neuromodulation (TMS/tACS) or anti‑tau antibodies in MCI and when will their results be reported?

Large, randomized anti‑tau antibody trials enrolling people with mild cognitive impairment (MCI) are actively underway and have staggered completion dates through 2027–2028, while the reporting provid...

Dec 19, 2025

Pharmaceutical companies recent investment in oncology

Pharmaceutical companies have sharply increased investment in oncology across R&D, licensing deals, M&A and manufacturing capacity, driven by a deep clinical pipeline, rising patient prevalence and th...